Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1447.95
6.25 (0.43%) Cipla informs about Press Release
Date: 04-06-2015Cipla has informed about Press Release dated June 03, 2015 titled ‘Cipla Announces US FDA Approval for the World's First Paediatric Lopinavir and ritonavir Oral Pellets for the Treatment of AIDS in Infants and Young Children’.
The above information is a part of company’s filings submitted to BSE.